Diagnosing Alzheimer's Disease: How to Innovate with Care
Diagnosing Alzheimer's Disease: How to Innovate with Care
复制标题
DOI：
10.1057/978-1-137-54097-3_14
复制
发表时间：
2016-01-01
期刊：
影响因子：
--
通讯作者：
Moors, Ellen
中科院分区：
文献类型：
--
作者：
Boenink, Marianne;van Lente, Harro;Moors, Ellen
本卷探讨了全球试图通过生物标志物或其他方式创新阿尔茨海默病（AD）的诊断。这种探索超出了记忆诊所和研究中心的范围，还包括报纸、政策文件、患者团体、全科医生和在线诊断工具等网站。网站的多样性反映了广告的许多面孔和表现形式：它不仅仅是一件事，而是很多。这种多样性使沿着的是，这种疾病的概念和如何解决它是难以捉摸的。诊断可以采取多种形式，并发挥不同的作用，并不是对每个人都同样重要。此外，探索AD表现的不同部位表明，AD是什么以及如何改进其诊断的想法经常受到争议。很明显，AD诊断的创新发生在一个难以捉摸和有争议的领域。那么，如何回答新兴诊断技术的可取性问题呢？
This volume has explored the global attempts to innovate the diagnostics of Alzheimer’s disease (AD), by means of biomarkers or otherwise. This exploration exceeded the confines of memory clinics and research centres, but also included sites such as newspapers, policy documents, patient groups, general practitioners, and online diagnostics tools. The diversity of sites reflects the many faces and manifestations of AD: it is not just one thing but many. This diversity brings along that the very notion of the disease and how it should be addressed are elusive. Diagnosis can take many forms and play different roles, and is not equally important for everyone. Moreover, exploring the different sites where AD manifests itself shows that ideas of what AD is and how its diagnostics should be improved often are contested. Innovation of AD diagnostics, so much is clear, takes place in an elusive and controversial field. How to answer, then, the question about the desirability of emerging diagnostic technologies?